Liu’s lab focuses on focuses on deciphering signaling events that drive cancer development, with the goal of developing new biomarkers for patient selection and identifying drug targets and potential therapeutics.

The UNC Program for Precision Medicine in Health Care (PPMH) and the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill (UNC-CH) have awarded 3 pilot grants.

photos of Pengda Liu PhD and Shelton Earp MD

In a study in Nature Communications, Pengda Liu, PhD, Shelton Earp, MD, and their collaborators reported discoveries about a key signaling pathway that can be hyperactive in kidney cancer.

Tag: Pengda Liu lab

Breast Cancer Alliance awards Liu 2020 Young Investigator grant

UNC Program for Precision Medicine in Health Care announces pilot grant awardees

Study provides insights behind hyperactivation of key cell proliferation signal